| Harry Shamoon, MD | |
|
Montefiore Medical Park, 1575 Blondell Avenue, Ste. 200, Bronx, NY 10461 | |
| (718) 405-8260 | |
| Not Available |
| Full Name | Harry Shamoon |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | Montefiore Medical Park, Bronx, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154410488 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 131785 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Harry Shamoon, MD 48 Edgewood Rd, Scarsdale, NY 10583-6421 Ph: (718) 405-8260 | Harry Shamoon, MD Montefiore Medical Park, 1575 Blondell Avenue, Ste. 200, Bronx, NY 10461 Ph: (718) 405-8260 |
News Archive
A higher rate of mortality is known to be associated with epilepsy, but the precise contribution of the underlying health factors is unknown. The results from the study of a large cohort of people born in Denmark in 1977 through 2006 were reported today at the American Epilepsy Society meeting here.
Based on current data measured in the energy, industry, and mobility sectors, restrictions of social life during the corona pandemic can be predicted to lead to a reduction of worldwide carbon dioxide emissions by up to eight percent in 2020.
Itamar-Medical's WatchPAT technology has been selected to The Top 10 Medical Innovations for 2010 at the seventh annual Cleveland Clinic Medical Innovation Summit. In developing the Top 10, Cleveland Clinic enlisted the expertise of AlixPartners, LLP, an independent international management advisory firm in order to develop a consensus perspective on the Top 10 Medical Innovations for 2010.
A researcher has developed probes that can help pinpoint the location of tumors and might one day be able to directly attack cancer cells.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that dosing with their first drug in its first Phase 1 study, was completed last week.
› Verified 7 days ago
Selina Sultana Zaman, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 600 E 233rd St, Bronx, NY 10466 Phone: 718-920-9000 | |
Dr. Jyothi B Kudakandira, M.D Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1650 Grand Concourse, Bronx, NY 10457 Phone: 718-960-1234 | |
Mana Rao, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Dr. Keshav Teelucksingh, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Tannaz Iranpour Boroujeni, M.D Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 600 E 233rd St, Bronx, NY 10466 Phone: 617-840-0110 | |
Heather Root, MD Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 111 E 210th St, Bronx, NY 10467 Phone: 718-920-8592 Fax: 718-405-0610 | |
Benjamin Tuttle Hayes, MD Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 305 E 161st St, Bronx, NY 10451 Phone: 718-579-2500 Fax: 718-579-2599 |